0.02
0.00%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Resapp Health
Its shares trade on ASX under the ticker RAP.AX. It has been listed since 12 January 2005. In the fiscal year to 30 June 2022, it reported revenue of A$2.5m and a net loss of A$7.1m. At that date it held total assets of A$5.8m and shareholders' equity of A$689,561.
ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The company is headquartered in Brisbane, Queensland. The company went IPO on 2005-01-12. The firm offers a range of solutions, such as telehealth, clinical use, direct consumer and big data insights. The firm provides point of care diagnostic solutions for telehealth companies, which is integrated into their platforms. The firm is working on applications to provide clinical quality diagnostic tests and management tools directly to consumers and healthcare providers. The firm is developing smartphone medical applications for the diagnosis and management of respiratory disease. The firm's technology is based on the premise that cough and breathing sounds carry vital information on the state of the respiratory tract. ResApp measures the severity of a range of chronic and acute diseases, such as pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease (COPD) using this insight.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 12 Jan 2005
- Employees
- 3
- Website
- resapphealth.com.au ↗
Leadership
Pay as last reported
- Dr. Roger AstonNon-Executive Chairman of the Board
- Mr. Mike ConnellVice President - Commercial
- Mr. Brian LeedmanExecutive Director, since 2016
- Ms. Nicki FarleyCompany Secretary, since 2012
- Mr. Simon LillDirector
- David MandelDirector, since 2009A$28,260
- Chris NtoumenopoulosNon-Executive Director
- Mr. Michael SteinNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Resapp Health Ltd possesses several strengths that contribute to its success in the healthcare industry. Firstly, the company's proprietary technology offers a non-invasive and convenient solution for diagnosing respiratory conditions. This provides a competitive advantage over traditional diagnostic methods.
- Furthermore, Resapp Health Ltd has a strong intellectual property portfolio, protecting their innovative technology and ensuring differentiation from competitors. This allows them to capitalize on their unique offering and maintain a strong market position.
Weaknesses
- Despite its strengths, Resapp Health Ltd also faces certain weaknesses that need to be addressed for sustainable growth. One such weakness is the company's heavy reliance on partnerships and collaborations for commercialization and market penetration. This dependence exposes the company to potential risks, such as partnership failures or delays in product development.
- Additionally, Resapp Health Ltd has limited financial resources compared to larger competitors in the industry. This could constrain their ability to invest in research and development, marketing efforts, and expanding their operations, potentially limiting their growth potential.
Opportunities
- Resapp Health Ltd operates in a rapidly growing digital health market, which presents various opportunities for future success. The increasing adoption of telehealth services and remote patient monitoring creates a favorable market environment for the company's respiratory diagnostic solutions. By positioning themselves as a leader in this space, Resapp Health Ltd can capitalize on the growing demand for convenient and accurate healthcare solutions.
- Furthermore, expanding their product offerings to cover other respiratory conditions and diseases opens up new avenues for revenue growth for Resapp Health Ltd. This diversification can help mitigate market risks and increase their market share.
Threats
- Resapp Health Ltd faces several potential threats within the healthcare industry. One significant threat is the high level of competition from both established players and emerging start-ups with similar respiratory diagnostic solutions. These competitors may have greater financial resources, larger customer bases, or stronger brand recognition, posing a challenge to Resapp Health Ltd's market position.
- Another threat is the ever-changing regulatory landscape in the healthcare industry. Compliance with evolving regulations and obtaining necessary approvals can be resource-intensive and time-consuming for Resapp Health Ltd. Failure to comply with regulatory requirements could result in delays or restrictions in product commercialization.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.